News
13h
GlobalData on MSNKling Bio and Sanofi link for antibodies and epitopes discoveryUsing patient-derived B cells, Kling-Select facilitates the rapid detection of new antibodies and preserved viral epitopes.
Sanofi's wide lineup of branded drugs and vaccines and robust pipeline create strong cash flows and a narrow economic moat. Growth of existing products and new product launches should help offset ...
A soon-to-be-released documentary film aims to change the conversation around hemophilia, a condition in which many female ...
Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...
Sulfonylureas as a whole are already known for their weight gain and hypoglycemia side effects. In practice, glipizide has ...
Casper claimed that during the quarter, Thermo Fisher advanced its growth strategy, launching a range of high-impact ...
NEW YORK: Edelman has hired Eduardo Tavares as global executive creative director of health, effective July 21. In his new ...
European pharmaceutical stocks have swooned while the broader market has climbed higher. As a result, stocks in the sector ...
The United States will stop distributing all influenza vaccines that contain mercury-based preservative thimerosal, marking ...
The global Enzyme Replacement Therapy (ERT) market is poised for significant expansion, projected to reach USD 21.62 billion ...
The trial will include patients with non-small cell lung, colorectal, head and neck, and cutaneous cancers with EGFR amplification.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results